Nalaganje...
Emerging drugs and combinations to treat multiple myeloma
In the past few years, multiple targeted therapies and immunotherapies including second generation immunomodulatory drugs (pomalidomide) and proteasome inhibitors (carfilzomib, ixazomib), monoclonal antibodies and checkpoint inhibitors were approved for the treatment of myeloma or entered advanced p...
Shranjeno v:
| izdano v: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals LLC
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5601169/ https://ncbi.nlm.nih.gov/pubmed/28948001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19269 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|